D. Oh

发表

Evidence for Overlapping Substrate Specificity Between Large Neutral Amino Acid (LNAA) and Dipeptide (hPEPTl) Transporters for PD 158473, an NMDA Antagonist

G. Amidon, W. Sadee, R. M. Williamson, 2004, Pharmaceutical Research.

5′-Amino Acid Esters of Antiviral Nucleosides, Acyclovir, and AZT Are Absorbed by the Intestinal PEPT1 Peptide Transporter

Wolfgang Sadee, W. Sadee, Chao-pin Lee, 1998, Pharmaceutical Research.

Drug transport and targeting. Intestinal transport.

G. Amidon, D. Oh, H. Han, 1999, Pharmaceutical biotechnology.

Pharmacokinetics and Pharmacodynamics of Nifedipine in Children with Bronchopulmonary Dysplasia and Pulmonary Hypertension

G. Amidon, R. Beekman, Cary E. Johnson, 1991, Pediatric Research.

Dissolution of ionizable water-insoluble drugs: the combined effect of pH and surfactant.

G L Amidon, J. Crison, G. Amidon, 2000, Journal of pharmaceutical sciences.

Improved intestinal transport of PD 158473, an N-methyl-D-aspartate (NMDA) antagonist, by involvement of multiple transporters.

Narayanan Surendran, Gordon L Amidon, Hyo-Kyung Han, 2002, Journal of pharmaceutical sciences.

Cellular Uptake Mechanism of Amino Acid Ester Prodrugs in Caco-2/hPEPT1 Cells Overexpressing a Human Peptide Transporter

G. Amidon, Hyo-Kyung Han, D. Oh, 1998, Pharmaceutical Research.

Absorption Rate Limit Considerations for Oral Phosphate Prodrugs

G. Flynn, J. Leppänen, D. Fleisher, 2003, Pharmaceutical Research.

Correlation between epithelial cell permeability of cephalexin and expression of intestinal oligopeptide transporter.

G. Amidon, X. Chu, K. Higaki, 2001, Journal of Pharmacology and Experimental Therapeutics.

Prediction of drug-drug interaction during oral absorption of carrier-mediated compounds in humans

G. Amidon, D. Oh, 1994 .

Characterization of the Oral Absorption of Some β-Lactams Effect of the α-Amino Side Chain Group

G. Amidon, P. Sinko, D. Oh, 1993 .

Predicting Oral Drug Absorption in Humans: A Macroscopic Mass Balance Approach for Passive and Carrier-Mediated Compounds

G. Amidon, P. Sinko, D. Oh, 1991 .

Integrated oral bioavailability projection using in vitro screening data as a selection tool in drug discovery.

Kjell Johnson, Adriaan Cleton, Hussein Hallak, 2004, International journal of pharmaceutics.

Effect of micronization on the extent of drug absorption from suspensions in humans

G. Amidon, R. Curl, C. Yong, 1995 .

Characteristics of ethylcellulose microcapsules of sulfisoxazole

D. Oh, Min Hwa Lee, 1982 .

Overview of membrane transport.

G. Amidon, D. Oh, 1999, Pharmaceutical biotechnology.

Estimating the Fraction Dose Absorbed from Suspensions of Poorly Soluble Compounds in Humans: A Mathematical Model

Gordon L. Amidon, G. Amidon, R. Curl, 1993, Pharmaceutical Research.

Enzyme-mediated precipitation of parent drugs from their phosphate prodrugs.

N. Rodríguez-Hornedo, D. Fleisher, T. Heimbach, 2003, International journal of pharmaceutics.

CHO/hPEPT1 cells overexpressing the human peptide transporter (hPEPT1) as an alternative in vitro model for peptidomimetic drugs.

G. Amidon, J. Rhie, D. Oh, 1999, Journal of pharmaceutical sciences.